BioCentury
ARTICLE | Company News

Exocell, Summit Pharmaceuticals deal

November 11, 1996 8:00 AM UTC

Summit received exclusive rights to market Exocell's Glycacor diabetes assay in Japan. Glycacor uses a monoclonal antibody to measure blood levels of glycated, low-density lipoprotein, which is correl...